The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
Quinapyramine sulfate ID: ALA1650565
PubChem CID: 136141534
Max Phase: Preclinical
Molecular Formula: C17H22N6O4S
Molecular Weight: 309.40
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Synonyms: Quinapyramine Sulfate
Canonical SMILES: Cc1cc(=N)c2ccc(Nc3cc(C)[n+](C)c(N)n3)cc2n1C.O=S(=O)([O-])O
Standard InChI: InChI=1S/C17H20N6.H2O4S/c1-10-7-14(18)13-6-5-12(9-15(13)22(10)3)20-16-8-11(2)23(4)17(19)21-16;1-5(2,3)4/h5-9H,1-4H3,(H3,18,19,20,21);(H2,1,2,3,4)
Standard InChI Key: LYZSIPLTVVBMHP-UHFFFAOYSA-N
Molfile:
RDKit 2D
28 29 0 0 0 0 0 0 0 0999 V2000
2.2812 -0.6875 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
2.2812 -1.5125 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.2812 0.1375 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.4562 -0.6875 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.1062 -0.6875 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-3.9668 -2.9820 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.9668 -3.8111 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.2528 -4.2234 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.2528 -2.5651 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.5341 -2.9820 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5331 -3.8111 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.8186 -4.2224 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.1005 -3.8093 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.1014 -2.9801 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.8206 -2.5642 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.6819 -2.5715 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.2540 -1.7406 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.2542 -5.0479 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.3875 -2.5678 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.3266 -2.9798 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3228 -3.8032 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0361 -4.2153 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7511 -3.8027 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.7482 -2.9740 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0343 -2.5657 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.4607 -2.5590 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.4657 -4.2138 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0359 -5.0398 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
1 3 2 0
1 4 1 0
1 5 1 0
6 16 1 0
9 17 1 0
6 7 2 0
8 18 2 0
6 9 1 0
14 19 1 0
7 8 1 0
19 20 1 0
8 11 1 0
20 21 2 0
10 9 1 0
21 22 1 0
10 15 1 0
22 23 2 0
11 12 1 0
23 24 1 0
12 13 2 0
24 25 2 0
25 20 1 0
13 14 1 0
24 26 1 0
14 15 2 0
23 27 1 0
10 11 2 0
22 28 1 0
M CHG 2 4 -1 23 1
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 309.40Molecular Weight (Monoisotopic): 309.1822AlogP: 1.82#Rotatable Bonds: 2Polar Surface Area: 83.60Molecular Species: BASEHBA: 5HBD: 3#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 4#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 8.97CX LogP: -2.80CX LogD: -4.38Aromatic Rings: 3Heavy Atoms: 23QED Weighted: 0.63Np Likeness Score: -0.73
References 1. Gillingwater K, Kumar A, Anbazhagan M, Boykin DW, Tidwell RR, Brun R.. (2009) In vivo investigations of selected diamidine compounds against Trypanosoma evansi using a mouse model., 53 (12): [PMID:19786604 ] [10.1128/aac.00422-09 ]